About
Neurostimulation
Areas of Focus
Categories
Uncategorized Medical Device
Clinical Trials (66)
View allTotal Trials
66
As Lead Sponsor
5
As Collaborator
61
Total Enrollment
64,307
By Phase
PHASE2: 13NA: 14PHASE1: 7PHASE3: 12PHASE1/PHASE2: 8PHASE2/PHASE3: 4PHASE4: 3EARLY_PHASE1: 2
By Status
COMPLETED: 40UNKNOWN: 9RECRUITING: 8ACTIVE_NOT_RECRUITING: 4NOT_YET_RECRUITING: 2TERMINATED: 2ENROLLING_BY_INVITATION: 1
Clinical Trials Pipeline66 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Today
Hover over trial bars to see details
Recent Trials
NCT06983210Collaborator
Clinical Trial of AM80 in Combination With Gemcitabine, Cisplatin, and Nivolumab in Patients With Urothelial Carcinoma
PHASE2Recruiting
43 participants
Started: May 1, 2025 · Completed: Mar 1, 2029
NCT06853990Lead Sponsor
Innovative Automated Insulin Delivery System for Type 2 Diabetes
NARecruiting
300 participants
Started: Apr 14, 2025 · Completed: Jun 30, 2026
NCT06853496Collaborator
Study of a Tankyrase Inhibitor RK-582 for Patients With Unresectable Metastatic Colorectal Cancer
PHASE1Recruiting
48 participants
Started: Mar 13, 2025 · Completed: Mar 31, 2027
NCT07129694Collaborator
Obtain Safety and Effectiveness of CT-ACL001, a Regenerative Ligament Using Biological Tissue, in ACLR
NAEnrolling by invitation
64 participants
Started: Nov 25, 2024 · Completed: Nov 30, 2027
NCT06616961Collaborator
Efficacy and Safety of Semaglutide for Weight Loss in Overweight or Obese Adults in Bangladesh With or Without Type 2 Diabetes Mellitus
PHASE3Not yet recruiting
480 participants
Started: Nov 1, 2024 · Completed: Oct 31, 2026
Locations (1)
Headquarters
West Sussex, UK
Map
Loading map...